Coronary disease & ACS

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials

Eur Heart J Cardiovasc PharmacotherPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

In patients undergoing PCI with concomitant OAC indication, an abbreviated DAPT regimen reduced MCRB and major bleeding without increasing MACE or other ischaemic events.

Study context

Population
Patients with oral anticoagulation (OAC) indication undergoing PCI
Participants
7,665 patients5 studies
Comparison
Abbreviated vs prolonged DAPT
  • Abbreviated DAPTn = 3,843
  • Prolonged DAPTn = 3,822reference
Outcome
Co-primary: major or clinically relevant non-major bleeding (MCRB) and major bleeding
Methodological detailsstandard and network meta-analyses
  • Standard and network meta-analyses

Pooled result

As reported in the abstract

Abbreviated DAPT vs Prolonged DAPTRelative risk (CI)P value
MCRB
0.69(0.52–0.91)
P = 0.01
Major bleeding
0.70(0.52–0.95)
P = 0.01

Further pooled results

MCRB and major bleeding, network meta-analysis

Peri-procedural DAPT had highest probability to prevent MCRB vs short (4-6 weeks) and longer (≥3 months) DAPT
97.1
Peri-procedural DAPT had highest probability to prevent major bleeding
92.0%

Sensitivity analyses and meta-regressions

Consistency across clinical scenarios; larger bleeding reduction with P2Y12 inhibitors vs aspirin after DAPT discontinuation suggested

All-cause death, CV death, stent thrombosis, MI

Did not differ

Safety

OutcomeRR (CI)P value
MACE (key safety endpoint)0.96 (0.70–1.33)P = 0.6

Original publication

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. Published 25 November 2022. doi:10.1093/ehjcvp/pvac065

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.